Medicare Enrolled
Dr. Stephen Gollomp, MD
Clinical Neurophysiology Physician · Wynnewood, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gollomp from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gollomp?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gollomp
Dr. Stephen Gollomp is a clinical neurophysiology physician in Wynnewood, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Gollomp performed 51,879 Medicare services across 1,911 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gollomp received a total of $124,433 from 69 pharmaceutical and/or device companies across 710 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in clinical neurophysiology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gollomp is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 5% volume in PA
$124,433 industry payments
Medicare Practice Summary
Medicare Utilization ↗51,879
Medicare services
Top 5% in PA for clinical neurophysiology physician
1,911
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,470 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection (Xeomin), per unit An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit. |
40,800 | $4 | $6 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
8,000 | $5 | $6 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
514 | $63 | $100 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
497 | $142 | $225 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
369 | $88 | $175 |
| Brain stimulator programming, additional 15 minutes Electronic analysis and programming of an implanted brain neurostimulator generator by a qualified health professional. This code applies to each additional 15-minute increment beyond the initial service. |
252 | $35 | $100 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
237 | $49 | $75 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 163 | $66 | $120 |
| Brain stimulator programming, first 15 minutes Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes. |
158 | $40 | $110 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
156 | $66 | $145 |
| Chemical nerve block for facial paralysis Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face. |
142 | $137 | $350 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
134 | $178 | $400 |
| New patient office visit, complex (60-74 min) | 112 | $172 | $400 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
90 | $27 | $70 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
87 | $44 | $74 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
40 | $70 | $110 |
| Chemical nerve block injection, 1-4 muscles An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated. |
34 | $122 | $500 |
| Online digital E/M service, established patient, 11-20 min An online digital evaluation and management service for an established patient. The service involves a total time of 11 to 20 minutes over a period of up to 7 days. |
33 | $24 | $45 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
25 | $46 | $125 |
| Online digital evaluation for established patient, 5-10 minutes This service involves an online digital evaluation and management visit for an established patient. It covers a total time of 5 to 10 minutes over a period of up to 7 days. |
24 | $11 | $25 |
| Telephone or internet assessment, 11-20 minutes A remote consultation conducted via telephone or internet that includes verbal discussion and a written report, lasting between 11 and 20 minutes. |
12 | $30 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$124,433
Total received (2018-2024)
Avg $17,776/year across 7 years
Top 8% in PA for clinical neurophysiology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
710
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$76,932 (61.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,352 (22.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$20,149 (16.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,776
2023
$33,176
2022
$16,574
2021
$19,199
2020
$20,285
2019
$22,177
2018
$9,247
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amneal Pharmaceuticals LLC
$1,454
ABBVIE INC.
$288
Abbott Laboratories
$233
Medtronic, Inc.
$199
SK Life Science, Inc.
$198
Lilly USA, LLC
$187
ARGENX US, INC.
$158
Merz Pharmaceuticals, LLC
$147
PFIZER INC.
$112
Neurocrine Biosciences, Inc.
$99
Kyowa Kirin, Inc.
$89
Genentech USA, Inc.
$61
Teva Pharmaceuticals USA, Inc.
$56
TG Therapeutics, Inc.
$55
Novartis Pharmaceuticals Corporation
$53
Alexion Pharmaceuticals, Inc.
$46
Celgene Corporation
$44
MDD US Operations, LLC
$40
Lundbeck LLC
$39
Biogen, Inc.
$32
InSightec,Inc
$24
Acorda Therapeutics, Inc
$23
UCB, Inc.
$23
Eisai Inc.
$22
GE HEALTHCARE
$20
Xeris Pharmaceuticals, Inc.
$17
Neurelis, Inc.
$15
ACADIA Pharmaceuticals Inc
$15
JAZZ PHARMACEUTICALS INC.
$15
REVANCE THERAPEUTICS, INC.
$13
Top 3 companies account for 52.3% of 2024 payments
All-time payments by company (2018-2024) ›
Neurocrine Biosciences, Inc.
$32,080
Merz North America, Inc.
$29,362
Merz Pharmaceuticals, LLC
$13,527
Sunovion Pharmaceuticals Inc.
$8,652
Kyowa Kirin, Inc.
$7,009
ABBVIE INC.
$6,620
Allergan, Inc.
$3,980
AbbVie Inc.
$2,864
MERZ NORTH AMERICA, INC.
$2,418
Neurocrine BioSciences, Inc.
$2,385
ACADIA Pharmaceuticals Inc
$2,188
MDD US Operations, LLC
$2,179
Amneal Pharmaceuticals LLC
$1,688
Teva Pharmaceuticals USA, Inc.
$853
Boston Scientific Corporation
$804
Biogen, Inc.
$803
Abbott Laboratories
$625
Lilly USA, LLC
$570
UCB, Inc.
$464
SK Life Science, Inc.
$462
Novartis Pharmaceuticals Corporation
$390
Medtronic, Inc.
$313
Amgen Inc.
$251
Alexion Pharmaceuticals, Inc.
$251
ARGENX US, INC.
$236
GENZYME CORPORATION
$234
PFIZER INC.
$215
InSightec,Inc
$199
Genentech USA, Inc.
$193
Acorda Therapeutics, Inc
$189
Avanir Pharmaceuticals, Inc.
$183
Sumitomo Pharma America, Inc.
$182
Janssen Pharmaceuticals, Inc
$164
Adamas Pharmaceuticals, Inc.
$122
IDORSIA PHARMACEUTICALS US INC
$116
BOSTON SCIENTIFIC CORPORATION
$115
Biohaven Pharmaceuticals, Inc.
$115
Lundbeck LLC
$108
Greenwich Biosciences, Inc.
$107
Biohaven Pharmaceutical Holding Company Ltd.
$101
US WorldMeds, LLC
$89
Eisai Inc.
$86
EMD Serono, Inc.
$81
UPSHER-SMITH LABORATORIES LLC
$79
Celgene Corporation
$61
Xeris Pharmaceuticals, Inc.
$58
TG Therapeutics, Inc.
$55
GE HealthCare
$52
SANOFI-AVENTIS U.S. LLC
$50
Ipsen Biopharmaceuticals, Inc
$44
TG THERAPEUTICS, INC.
$41
Medtronic USA, Inc.
$41
Avion Pharmaceuticals
$39
Vertical Pharmaceuticals, LLC
$37
GE HEALTHCARE
$37
JAZZ PHARMACEUTICALS INC.
$35
Allergan Inc.
$31
Akcea Therapeutics, Inc.
$22
PORTOLA PHARMACEUTICALS, LLC
$20
Banner Life Sciences, LLC
$19
IMPEL PHARMACEUTICALS INC.
$18
GE Healthcare
$17
LivaNova USA, Inc.
$17
Neurelis, Inc.
$15
Otsuka America Pharmaceutical, Inc.
$15
Novo Nordisk Inc
$14
Amarin Pharma Inc.
$14
REVANCE THERAPEUTICS, INC.
$13
Impax Laboratories, Inc.
$13
Top 3 companies account for 60.2% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ACTIVA PC · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COMIRNATY · COPAXONE · DAXI · DUOPA · DYSPORT · Dhivy · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · Exablate · GENERAL DBS · GENERAL - DBS · GILENYA · GOCOVRI · GVOKE HYPOPEN · GVOKE PFS · Gocovri · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LYVISPAH · Leqembi · MAVENCLAD · MYOBLOC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Neuromodulation Dspsbls and Accs · Nourianz · Nuedexta · OCREVUS · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OSMOLEX ER · Ocrevus · Ocrevus Zunovo · Ongentys · PAXLOVID · PERCEPT PC BRAINSENSE · Percept · Ponvory · QULIPTA · QUVIVIQ · RECLAIM · RYTARY · Rebif · SOLIRIS · Soliris · TECFIDERA · TEGSEDI · TOSYMRA · TYSABRI · Tresiba · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vascepa · Vercise · XCOPRI · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (62%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in clinical neurophysiology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for clinical neurophysiology physician in PA.
Geographic Context
Clinical neurophysiology physicians within 10 mi
8
Per 100K population
0.9
County median income
$111,521
Nearest hospital
MAIN LINE HOSPITAL LANKENAU
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gollomp is a mixed practice specialist, with above-average Medicare volume (top 5% in PA), with speaking/promotional industry engagement in the top 8% of PA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gollomp experienced with botox injection (xeomin), per unit?
Based on Medicare claims data, Dr. Gollomp performed 40,800 botox injection (xeomin), per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gollomp receive payments from pharmaceutical companies?
Yes. Dr. Gollomp received a total of $124,433 from 69 companies across 710 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gollomp's costs compare to other clinical neurophysiology physicians in Wynnewood?
Dr. Gollomp's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gollomp) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Clinical Neurophysiology Physicians in Wynnewood
Browse clinical neurophysiology physicians in Wynnewood ranked by procedure volume and transparency data.
Highest volume
Top Clinical Neurophysiology Physicians in PA
Clinical neurophysiology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Clinical Neurophysiology Physicians in PA
Which PA clinical neurophysiology physicians receive the most from drug and device companies.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
Merz North America, Inc. Payments to Doctors
See all physicians who received payments from Merz North America, Inc.
By company
Merz Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from Merz Pharmaceuticals, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology